Silverarc Capital Management, LLC Brickell Biotech, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.71 - $2.08 $17,100 - $20,800
10,000 New
10,000 $17,000

Others Institutions Holding BBI

# of Institutions
1
Shares Held
65K
Call Options Held
0
Put Options Held
0
View Full List

About Brickell Biotech, Inc.

BBI Quotes by TradingView
  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email